The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)

端粒缩短在 MDS-AML 发病机制中的作用(重新提交)

基本信息

  • 批准号:
    8435373
  • 负责人:
  • 金额:
    $ 31.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-03-01 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Telomeres are essential for the maintenance of genomic integrity. Dyskeratosis congenita (DC) is a cancer- prone syndrome characterized by short telomeres. Affected patients have an increased risk for developing hematologic malignancies, specifically myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). While DC is an inherited Mendelian disorder, germline mutations in telomerase and telomere components are identifiable in only two-thirds of families, leaving the causal mutations in the remaining cases uncharacterized. Mutations in DC genes also underlie inheritance in a subset of MDS and AML families. This fact, along with the observation that MDS-AML patients have short telomeres, has suggested an intimate role for telomere length in the genetics of these disorders. This project examines two aspects of DC genetics and biology of relevance to understanding MDS-AML pathogenesis. We aim to identify novel genes that are critical for telomere maintenance by studying genetically uncharacterized DC families in a registry we have established. Given the known limitations of traditional linkage approaches in small kindreds, the cohort we have compiled provides an ideal setting to apply next-generation sequencing technologies for the purpose of gene discovery. In Aim 2, we examine the biology by which short telomeres promote MDS-AML in an animal model of DC we have characterized. This murine model uniquely recapitulates human telomere length dynamics. The proposed studies in DC have particular significance for understanding the biology of MDS-AML since the telomere defect found in DC patients is universally acquired with aging, and the biology that underlies the increasing incidence of MDS-AML with age is not understood. Broadly, they have implications for understanding fundamental questions regarding the role of telomere length in cancer risk and progression.
描述(申请人提供):端粒对于维持基因组的完整性是必不可少的。先天性角化不良(DC)是一种以端粒较短为特征的癌症易感综合征。受影响的患者患恶性血液病的风险增加,特别是骨髓增生异常综合征(MDS)和急性髓系白血病(AML)。虽然DC是一种遗传性孟德尔疾病,但只有三分之二的家庭可识别出端粒酶和端粒成分的胚系突变,其余病例的因果突变尚不明确。DC基因突变也是MDS和AML家族子集遗传的基础。这一事实,以及观察到MDS-AML患者端粒较短,表明端粒长度在这些疾病的遗传学中起着密切的作用。这个项目考察了DC遗传学和生物学的两个方面,它们与理解MDS-AML的发病机制有关。我们的目标是通过在我们建立的注册表中研究未表现出遗传特征的DC家族来识别对端粒维持至关重要的新基因。考虑到传统连锁方法在小家庭中的已知局限性,我们汇编的队列为应用下一代测序技术达到基因发现的目的提供了一个理想的环境。在目标2中,我们在我们所描述的DC动物模型中检查了短端粒促进MDS-AML的生物学。这个小鼠模型独特地概括了人类端粒长度的动力学。DC的研究对于了解MDS-AML的生物学具有特别重要的意义,因为DC患者中发现的端粒缺陷是随着年龄的增长而普遍获得的,而MDS-AML随年龄增加的生物学基础尚不清楚。广泛地说,它们对于理解关于端粒长度在癌症风险和进展中的作用的基本问题具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary Y Armanios其他文献

Mary Y Armanios的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary Y Armanios', 18)}}的其他基金

Cancer Genetics of Short Telomere Syndromes
短端粒综合征的癌症遗传学
  • 批准号:
    10434717
  • 财政年份:
    2018
  • 资助金额:
    $ 31.6万
  • 项目类别:
Cancer Genetics of Short Telomere Syndromes
短端粒综合征的癌症遗传学
  • 批准号:
    10199960
  • 财政年份:
    2018
  • 资助金额:
    $ 31.6万
  • 项目类别:
Mechanisms of Telomere-Induced Emphysema
端粒诱发肺气肿的机制
  • 批准号:
    8894574
  • 财政年份:
    2014
  • 资助金额:
    $ 31.6万
  • 项目类别:
Mechanisms of DNA damage induced emphysema
DNA损伤诱发肺气肿的机制
  • 批准号:
    10431937
  • 财政年份:
    2014
  • 资助金额:
    $ 31.6万
  • 项目类别:
Mechanisms of DNA damage induced emphysema
DNA损伤诱发肺气肿的机制
  • 批准号:
    10187637
  • 财政年份:
    2014
  • 资助金额:
    $ 31.6万
  • 项目类别:
Mechanisms of Telomere-Induced Emphysema
端粒诱发肺气肿的机制
  • 批准号:
    8762045
  • 财政年份:
    2014
  • 资助金额:
    $ 31.6万
  • 项目类别:
Mechanisms of Telomere-Induced Emphysema
端粒诱发肺气肿的机制
  • 批准号:
    9258486
  • 财政年份:
    2014
  • 资助金额:
    $ 31.6万
  • 项目类别:
Mechanisms of DNA damage induced emphysema
DNA损伤诱发肺气肿的机制
  • 批准号:
    10636855
  • 财政年份:
    2014
  • 资助金额:
    $ 31.6万
  • 项目类别:
Mechanisms of DNA damage induced emphysema
DNA损伤诱发肺气肿的机制
  • 批准号:
    9917077
  • 财政年份:
    2014
  • 资助金额:
    $ 31.6万
  • 项目类别:
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
端粒缩短在 MDS-AML 发病机制中的作用(重新提交)
  • 批准号:
    8246709
  • 财政年份:
    2012
  • 资助金额:
    $ 31.6万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 31.6万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了